We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FWONA:NASDAQLiberty Media Corporation - Series A Liberty Formula One Analysis

Data as of 2026-06-12 - not real-time

$83.30

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Formula One Group (FWONA) is currently trading above its discounted cash flow estimate, indicating a premium valuation. The stock’s price sits above both the 20‑day and 50‑day moving averages, yet the MACD histogram is negative and volume is on a downtrend, suggesting short‑term downside pressure. The relative strength index hovers around the neutral zone, and market sentiment is marked by extreme greed, which may be inflating the price. Fundamentally, the company reports robust revenue growth and solid operating margins, but its price‑to‑earnings multiple is well above the industry average, reflecting growth expectations that are already priced in.
Looking ahead, the recent strategic acquisition of MotoGP could broaden the content portfolio and open new monetization channels, supporting a longer‑term growth narrative. However, the elevated valuation, modest cash generation relative to debt, and decreasing liquidity indicators temper enthusiasm. Investors should weigh the upside from expanded global fan engagement against the risk of a valuation correction, especially if short‑term technical signals turn more bearish.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • bearish MACD histogram
  • decreasing volume trend
  • price trading above DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • neutral trend with SMA alignment
  • steady revenue growth
  • high valuation relative to peers

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • strategic MotoGP acquisition expanding content portfolio
  • strong global brand and fan base
  • potential upside from new media monetization

Key Metrics & Analysis

Financial Health

Revenue Growth18.30%
Profit Margin5.57%
P/E Ratio36.4
ROE2.73%
ROA2.22%
Debt/Equity59.88
P/B Ratio2.6
Op. Cash Flow$793.0M
Free Cash Flow$654.2M
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI54.7
Support$78.63
Resistance$85.83
MA 20$82.27
MA 50$81.95
MA 200$85.10
MACDBearish
VolumeDecreasing
Fear & Greed Index86.71

Valuation

Fair Value$56.82
Target Price$107.83
Upside/Downside29.45%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.41
Volatility27.54%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.